Fapon Unveils AI‑Engineered Enzymes and Alzheimer’s Reagents at ADLM 2026
Fapon Unveils AI‑engineered enzymes and Alzheimer’s reagents at ADLM 2026 – The North‑American‑focused IVD supplier is using generative‑AI‑designed enzymes and a new suite of blood‑based Alzheimer’s biomarkers to stake a claim in the rapidly expanding AI‑driven diagnostics market. Why AI‑Engineered Enzymes Matter Fapon, a global life‑science company, took center stage at the American Association for Clinical…
